Navigation Links
Pam Marrone to Speak at Ag 2.0 Conference
Date:4/8/2011

DAVIS, Calif., April 8, 2011 /PRNewswire/ -- On April 12, at the Hilton San Francisco Union Square, Pam Marrone, Founder and CEO of Marrone Bio Innovations (MBI), will address Agriculture 2.0 conference attendees as part of an industry panel debating the topic of 'Feeding a Growing Global Population'. The discussion will explore technologies with the potential to curb environmental impact while producing enough food to feed a projected world population of 9 billion people by 2050.

Marrone's company, Marrone Bio Innovations, discovers, develops and markets effective and environmentally responsible products that fill unmet needs for weed, plant disease and invasive pest management. The company plays a leading role in developing and supplying effective, natural agricultural products that meet the challenge of delivering higher yields while maintaining a sustainable food production system.

In its 5th annual conference on April 11 & 12, 2011, Ag 2.0 brings together venture capitalists and early-stage companies, as well as senior decision makers in agribusiness and farmland funds, commodities experts, growth stage and institutional investors, and key industry insiders and policy makers. The conference provides a forum for hundreds of investors, entrepreneurs and industry experts to hold panel discussions, presentations, industry roundtables and networking sessions with individuals who will work to catalyze and capitalize sustainable agriculture as an asset class.

About Marrone Bio Innovations

Marrone Bio Innovations (MBI) discovers, develops and markets effective and environmentally responsible natural products that fill unmet needs for weed, plant disease and pest management. MBI's effective and safe products come from a combination of in-licensed technology and its own discovery. The company's own R&D finds naturally occurring microorganisms from unique habitats and develops them into pest management products. MBI has an impressive pipeline of new products waiting approval at the EPA, including two insecticides, two herbicides and Zequanox,™ a product for controlling invasive zebra and quagga mussels in fresh waterways. MBI has several new nematicide, insecticide, fungicide and herbicide candidates from its discovery screen.  In addition to its award-winning Regalia® Biofungicide, MBI currently markets GreenMatch®Burndown Herbicide for weed control in organic crop production.  For more information about Marrone Bio Innovations, please go to www.marronebio.com


'/>"/>
SOURCE Marrone Bio Innovations
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Marrone Bio Innovations to Present Invasive Mussel Control Solution
2. Marrone Bio Innovations Announces Two New Executive Appointments
3. Marrone Bio Innovations Named an IC20 Company
4. Pharma ChemOutsourcing 2011 Unveils First Wave of 50 Biotech Chemist Speakers for September 12-15 Show in New Jersey
5. Science advisor to the US EPA to speak to industry, academic leaders on sustainability innovations
6. PRA International Expert to Speak at China Drug Safety Summit
7. Tianyins Dr. James Jiayuan Tong is Invited to Speak at the CFO China Summit 2011 on January 19, 2011 at the St. Regis Hotel, Beijing
8. Accuray Incorporated to Speak at Seventh Annual Lazard Capital Markets Healthcare Conference
9. Pfizer, Merck, Roche/Genentech, GSK, J&J, BMS and More to Speak at Contracting & Outsourcing 2010
10. Aneesh Chopra Joins 2010 mHealth Summit as Keynote Speaker
11. Bill Gates Named Keynote Speaker at the 2010 mHealth Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge ... envision new ways to harness living systems and biotechnology, ... Art (MoMA) in New York City ... 130 participating students, showcased projects at MoMA,s Celeste Bartos ... Paola Antonelli , MoMA,s senior curator of architecture and ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... Prairie, WI (PRWEB) , ... June 23, 2016 ... ... consultancy focused on quality, regulatory and technical consulting, provides a free webinar ... is presented on July 13, 2016 at 12pm CT at no charge. , ...
(Date:6/22/2016)... Research and Markets has announced the addition ... their offering. The global ... billion in 2013. The market is expected to grow at a ... 2020, increasing from $50.6 billion in 2015 to $96.6 billion in ... forecast period (2015 to 2020) are discussed. As well, new products ...
Breaking Biology Technology:
(Date:5/24/2016)... IRVINE, Calif. , May 24, 2016 Ampronix facilitates superior patient care ... LMD3251MT  3D medical LCD display is the latest premium product recently added to ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com , ... published the overview results from the Q1 wave of ... recent wave was consumers, receptivity to a program where ... with a health insurance company. "We were ... share," says Michael LaColla , CEO of Troubadour ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) ... financial services, but it also plays a fundamental part in ...
Breaking Biology News(10 mins):